CC2.png
ChemioCare Announces Appointment of Roy F. Waldron to Its Board of Directors
29 avr. 2019 07h50 HE | ChemioCare
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the appointment of...